February 1, 2022
1 min read

US FDA okays Moderna’s Covid-19 jab for adults

Spikevax meets the FDA’s rigorous standards for safety, effectiveness and manufacturing quality required for approval…reports Asian Lite News

Moderna’s Covid-19 vaccine has received full approval from the US Food and Drug Administration (FDA).

The vaccine, named Spikevax, is approved for use in people ages 18 and older, Xinhua news agency reported.

Spikevax meets the FDA’s rigorous standards for safety, effectiveness and manufacturing quality required for approval, said the agency in a statement.

“While millions of people have already safely received Covid-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated,” said Acting FDA Commissioner Janet Woodcock.

“Today’s milestone puts us one step closer to altering the course of this pandemic in the US,” she said.

Moderna’s Covid-19 vaccine is the second one in the US to receive full approval from the FDA. Pfizer’s Covid-19 vaccine, Comirnaty, was fully approved for use in people ages 16 and older in August 2021.



Moderna’s Covid-19 vaccine has been available under the FDA’s emergency use authorization for individuals 18 years of age and older since December 18, 2020.

Moderna had earlier began clinical trials of a booster dose of a vaccine designed specifically to combat the Omicron variant of COVID-19.

CNN reported that the trials will involve a total of 600 adults, which will take place at up to 24 sites in the US. Some participants will have already received two doses of Moderna’s vaccine, and some will have received a booster shot.

“We are reassured by the antibody persistence against Omicron at six months after the currently authorized 50 mg booster of mRNA-1273. Nonetheless, given the long-term threat demonstrated by Omicron’s immune escape, we are advancing our Omicron-specific variant vaccine booster candidate and we are pleased to begin this part of our Phase 2 study,” CNN citing CEO Stephane Bancel’s statement reported.

“We are also evaluating whether to include this Omicron-specific candidate in our multivalent booster program,” it added.

ALSO READ: US Pentagon chief, Amir of Qatar hold talks on Afghanistan

Previous Story

Third-wave fear on ‘CLOTH MASK’

Next Story

US to impose sanctions on Putin’s aides

Latest from -Top News

BRICS must break the digital chains

BRICS nations need to build consensus, balance innovation and social justice by reinforcing the digital sovereignty of Global South, including evenly distribution of benefits through AI, writes Baidya Bikash Basu BRICS, the

Modi begins landmark Argentina visit

First Indian PM to visit in 57 years; economic ties, lithium and trade top agenda Prime Minister Narendra Modi kicked off a historic visit to Argentina on Saturday by paying homage to

Texas flash floods kill at least 24; Trump vows help

President calls tragedy ‘shocking’ as search for missing continues overnight At least 24 people have died in Kerr County, Texas, after catastrophic flooding swept through the region, prompting a large-scale rescue and
Go toTop

Don't Miss

U.S. Grains Council opens new office in Delhi

The Council has been in India for more than 25

China cannot cover for impact of sanctions on Russia: White House

When asked whether the US was prepared to accept refugees